DekaBank Deutsche Girozentrale’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.5M Buy
113,193
+151
+0.1% +$48.7K 0.07% 239
2025
Q1
$30M Sell
113,042
-151
-0.1% -$40.1K 0.06% 254
2024
Q4
$26.5M Hold
113,193
0.05% 278
2024
Q3
$30.9M Sell
113,193
-270
-0.2% -$73.6K 0.06% 261
2024
Q2
$27.9M Buy
113,463
+421
+0.4% +$103K 0.05% 266
2024
Q1
$17.3M Sell
113,042
-24,843
-18% -$3.81M 0.03% 347
2023
Q4
$26.8M Sell
137,885
-5,215
-4% -$1.01M 0.06% 274
2023
Q3
$24.8M Sell
143,100
-17,349
-11% -$3.01M 0.06% 277
2023
Q2
$30.6M Buy
160,449
+36,404
+29% +$6.93M 0.07% 253
2023
Q1
$24M Buy
124,045
+33,692
+37% +$6.51M 0.06% 272
2022
Q4
$21.3M Buy
90,353
+1,962
+2% +$463K 0.06% 277
2022
Q3
$18.4M Buy
88,391
+18,804
+27% +$3.91M 0.05% 275
2022
Q2
$9.99M Buy
69,587
+12,419
+22% +$1.78M 0.03% 385
2022
Q1
$9.52M Buy
57,168
+889
+2% +$148K 0.02% 432
2021
Q4
$9.54M Buy
56,279
+11,843
+27% +$2.01M 0.02% 429
2021
Q3
$7.9M Sell
44,436
-29,155
-40% -$5.18M 0.02% 432
2021
Q2
$12.1M Sell
73,591
-104
-0.1% -$17.1K 0.04% 337
2021
Q1
$9.91M Buy
73,695
+2,047
+3% +$275K 0.03% 356
2020
Q4
$9.32M Sell
71,648
-10,540
-13% -$1.37M 0.04% 335
2020
Q3
$12M Buy
82,188
+74,464
+964% +$10.8M 0.05% 262
2020
Q2
$1.14M Buy
7,724
+1,685
+28% +$248K 0.01% 624
2020
Q1
$650K Sell
6,039
-239
-4% -$25.7K 0.01% 700
2019
Q4
$731K Sell
6,278
-52,301
-89% -$6.09M ﹤0.01% 762
2019
Q3
$4.77M Sell
58,579
-51,300
-47% -$4.17M 0.03% 360
2019
Q2
$7.84M Buy
109,879
+64,339
+141% +$4.59M 0.04% 348
2019
Q1
$5.61M Buy
45,540
+9,428
+26% +$1.16M 0.03% 403
2018
Q4
$2.53M Sell
36,112
-9,428
-21% -$660K 0.02% 489
2018
Q3
$5.61M Sell
45,540
-7,588
-14% -$934K 0.03% 408
2018
Q2
$5.24M Sell
53,128
-12,978
-20% -$1.28M 0.03% 384
2018
Q1
$8.64M Buy
66,106
+6,246
+10% +$816K 0.06% 311
2017
Q4
$4.86M Hold
59,860
0.04% 379
2017
Q3
$4.86M Sell
59,860
-5,500
-8% -$447K 0.04% 381
2017
Q2
$5.14M Hold
65,360
0.04% 374
2017
Q1
$3.34M Buy
65,360
+24,850
+61% +$1.27M 0.03% 413
2016
Q4
$1.62M Buy
40,510
+676
+2% +$27.1K 0.02% 470
2016
Q3
$2.78M Sell
39,834
-700
-2% -$48.9K 0.03% 403
2016
Q2
$2.26M Sell
40,534
-1,450
-3% -$80.7K 0.03% 444
2016
Q1
$2.49M Sell
41,984
-10,090
-19% -$598K 0.03% 425
2015
Q4
$4.92M Buy
52,074
+550
+1% +$52K 0.06% 321
2015
Q3
$4.14M Buy
51,524
+2,824
+6% +$227K 0.05% 344
2015
Q2
$5.84M Buy
48,700
+9,430
+24% +$1.13M 0.07% 270
2015
Q1
$4.1M Sell
39,270
-1,680
-4% -$175K 0.05% 351
2014
Q4
$3.97M Sell
40,950
-3,750
-8% -$364K 0.05% 348
2014
Q3
$3.49M Buy
44,700
+1,350
+3% +$105K 0.05% 337
2014
Q2
$2.74M Buy
43,350
+5,550
+15% +$351K 0.04% 363
2014
Q1
$2.54M Buy
37,800
+1,900
+5% +$128K 0.04% 348
2013
Q4
$2.32M Buy
35,900
+1,200
+3% +$77.4K 0.04% 303
2013
Q3
$2.22M Buy
+34,700
New +$2.22M 0.04% 307